ELECTRONIC HEALTH RECORDS AND DIGITAL TRIALS

 

 

Electronic Health Records EHR are becoming a new standard. As traditional records are moved over to Electronic we are seeing a new opportunity to gather value from this data from assessing care pathways to discovering value from drugs in real world settings and bringing together cohorts for clinical trails along with generating phenotypic/genotypic relations through functional genomics.

THIS YEAR’S WORLD LEADING ELECTRONIC HEALTH RECORDS AND DIGITAL TRIALS SPEAKERS

 

 

 

EHR & Digital Trials, Tuesday 2 November 2021

08:40

Opening Remarks

Trevor Howe
09:00

Looking at the bigger picture: How do we make sure that we have the full picture with big data experiments

Joachim Reischl
09:20

Deep Medicine – towards the next generation of software-based precision medicine diagnostics

  • Evolution of precision medicine
  • AI in predicting clinical outcome
  • Software as Medical Device as Companion Diagnostic
Panel discussion
09:40

Essential Tools for Accelerating Pipeline Productivity & Success

What tools are in your toolkit? Join this leading biopharma panel discussion to find out how to give your AI-based drug discovery and development program a competitive edge and increase program success.
10:40

Networking Break

13:20

Networking Lunch Break

16:20

Networking Break

18:00

Neri & Sons Band & Networking Drinks Reception

last published: 27/Jul/21 14:25

EHR & Digital Trials, Wednesday 3 November 2021

Steffen Roellinger
09:00

Decentralised Clinical Trials

  • Discussing the adoption of decentralised clinical trials at Bayer
  • New digital addoption
  • The Bayer trials transformaiton over COVID-19
Andrew Kasarskis
09:00

Digital transformation over COVID-19 – Challenges for the future and perpetuating the efforts

  • COVID-19 lead to digital innovation by necessity, including telehealth, new apps and digital technologies, and data fusion and sharing advances.
  • Large opportunities exist to do much better with learning from data, however.This requires the following operational and cultural change:
-Proactive collection and use of coherent data sets as a baseline for public health and the infrastructure development to support that work.-Recommitment to evidence-based medicine and timely, rigorous assessment of clinical utility through ongoing clinical research with well-powered studies of strong statistical design coupled to careful monitoring of large observational data.
Said Ismail
09:20

Qatar Genome; Big data from an underrepresented region

  • Overview of the Qatar Genome Project (QGP)
  • Contributions to Middle East Genomics
  • QGP role COVID-19 research
  • Strategy for precision medicine implementation
09:20

SevenBridges

Panel discussion
09:40

BC Platforms - Keynote Panel

Paul Agapow
09:40

How to be right: effective use of clinical models and machine learning in the clinic

    There is an increasing demand for a sophisticated model to predict patient outcomes and suggest treatmentsUnfortunately, most proposed clinical models are not fit for purpose, being biased, unvalidated, or irrelevantHere we suggest best practices for the development and deployment of complex ML algorithms, resulting in more successful and effective models
10:20

Networking Break + Speed Networking

13:00

Networking Lunch Break

16:00

Networking Break

18:00

Drinks Reception

last published: 27/Jul/21 14:25

EHR & Digital Trials, Thursday 4 November 2021

Scott Chandler
09:00

Genetic Drivers of Response to Immunotherapy: Going Beyond the Tumor

09:20

GenomeSys

Thomas Hach
10:40

The Future of Precision Healthcare – Multi-Omics Humanized

  • Personalization of healthcare, not only of drug treatment, is the future
  • Patient influence, patient data and patient-desired outcomes are the most disruptive factors
  • How can we move from sterile biosignatures to a humanized approach?
EHR & Digital Trials
11:45

Chair's Remarks

David Pearce
EHR & Digital Trials
11:50

Rare Disease registries and extraction of real-world data to expedite diagnosis and treatment development: A sound economic understanding for all rare disease stakeholders

EHR & Digital Trials
12:10

Sponsor

Daniel Zahnd
EHR & Digital Trials
12:30

Inpatient Trajectories in Switzerland: Building Disease Groups over Time for Comprehensive Clinical Outcome Evaluation and Clinical Trials

  • Vertical and horizontal integration of inpatient episodes through the hospital system allow a new perspective for the journeys of patients through the health system
  • Rehospitalisation’s and complications are monitored and brought into a comprehensive disease stages concept including risk factors and prognosis of future disease courses
  • Covering the full spectrum of inpatient conditions and potential reference framework for ex post clinical trials
Michael Chapman
EHR & Digital Trials
14:00

Developing the NHS “data engine room” for clinical trials

EHR & Digital Trials
14:30

Sponsor

Mohammadreza Yazdannasab
EHR & Digital Trials
14:50

Advantages of Blockchain Technology in Health Data Management

EHR & Digital Trials
15:10

Sponsor

Hannelore Aerts
EHR & Digital Trials
15:30

Presentation

Hannelore Aerts, Data Quality Programme Manager, European Institute For Innovation Through Health Data And European Institute For Health Records
last published: 27/Jul/21 14:25

GET INVOLVED AT BIODATA WORLD CONGRESS

 

 

TO SPONSOR


Alistair Wilmot
alistair.wilmot@terrapinn.com
0207 092 1174

 

 

TO SPEAK


Edward Glanville

edward.glanville@terrapinn.com
0207 092 1042

 

 

MARKETING OPPORTUNITIES


Onika Akhtar
onika.akhtar@terrapinn.com
0207 092 1034